Israel Englander Harmony Biosciences Holdings, Inc. Call Options Transaction History
Millennium Management LLC
- $192 Billion
- Q4 2024
Call Options
2 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$233 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$206 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$167 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$80.4 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$55.8 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.09B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...